Nan Shan Life Insurance’s AGNC Investment AGNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-9,336,523
Closed -$120M 106
2020
Q2
$120M Sell
9,336,523
-300
-0% -$3.76K 3.65% 5
2020
Q1
$98.8M Sell
9,336,823
-2,478,207
-21% -$41.3M 3.61% 7
2019
Q4
$209M Hold
11,815,030
6.51% 3
2019
Q3
$190M Sell
11,815,030
-100,000
-0.8% -$1.64M 5.24% 3
2019
Q2
$200M Sell
11,915,030
-711,630
-6% -$12.4M 5.13% 3
2019
Q1
$227M Buy
12,626,660
+844,234
+7% +$15.1M 4.48% 2
2018
Q4
$207M Buy
11,782,426
+1,354,501
+13% +$24.1M 4.93% 3
2018
Q3
$194M Sell
10,427,925
-960,688
-8% -$18.3M 3.77% 4
2018
Q2
$212M Sell
11,388,613
-1,413,628
-11% -$26.7M 4.88% 3
2018
Q1
$242M Buy
12,802,241
+7,844,625
+158% +$149M 4.94% 4
2017
Q4
$100M Sell
4,957,616
-1,719,990
-26% -$35.4M 2.6% 11
2017
Q3
$145M Sell
6,677,606
-1,118,817
-14% -$23.9M 2.99% 11
2017
Q2
$166M Sell
7,796,423
-2,312,776
-23% -$48.1M 4.22% 6
2017
Q1
$201M Buy
10,109,199
+7,109,199
+237% +$137M 5.01% 4
2016
Q4
$54.4M Buy
+3,000,000
New +$56.9M 2.06% 14

Other funds holding AGNC

Nan Shan Life Insurance's AGNC Position: Q3 2020 in Review

Nan Shan Life Insurance sold out of AGNC Investment (AGNC) in Q3 2020, closing a stake of 9,336,523 shares — an estimated $120M sold.

Nan Shan Life Insurance first reported a position in AGNC in Q4 2016 and held it in 15 quarters. The position peaked at $242M in Q1 2018. 446 funds tracked by Wall St. Rank hold AGNC as of Q3 2020.

  • Nan Shan Life Insurance reported no remaining AGNC Investment position as of Q3 2020 after selling out during the quarter.
  • Nan Shan Life Insurance sold 9,336,523 AGNC Investment shares in Q3 2020, an estimated $120M.
  • Nan Shan Life Insurance first reported a position in AGNC Investment in Q4 2016 and held it in 15 quarters.
  • Nan Shan Life Insurance's AGNC Investment position peaked at $242M in Q1 2018.
  • 446 funds tracked by Wall St. Rank held AGNC Investment as of Q3 2020.

Based on Nan Shan Life Insurance's 13F filing for Q3 2020, filed 13 Nov 2020.